Drugs affordability vs R&D development

The US wants to cap drug prices without affecting R&D in the biopharma industry. The biopharma / biotech sector is upping its R&D investment, according to an April 21 Congressional Budget Office R&D trend – in 2019 the US...

Continue reading →

Flying cars – another fiction becomes reality

Continue reading →

Diamond market honey trap

Continue reading →